Buy Sun Pharma Advanced Research Company: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Sun Pharma Advanced Research Company (SPARC) had a very sharp correction – Rs 570 to Rs 400 and that is how volatile stocks behave. At Rs 400 it stopped its fall, it is building a small base, it’s an attractive buy. There is so much it can do and not do, but I would be a buyer here for the short-term and if the rally sustains I would also be looking to invest."

At 11:05 hrs Sun Pharma Advanced Research Company was quoting at Rs 424.60, up Rs 3.80, or 0.90 percent. It has touched an intraday high of Rs 429 and an intraday low of Rs 422.